Cargando…
Urinary proteome profiling for stratifying patients with familial Parkinson’s disease
The prevalence of Parkinson's disease (PD) is increasing but the development of novel treatment strategies and therapeutics altering the course of the disease would benefit from specific, sensitive, and non‐invasive biomarkers to detect PD early. Here, we describe a scalable and sensitive mass...
Autores principales: | Virreira Winter, Sebastian, Karayel, Ozge, Strauss, Maximilian T, Padmanabhan, Shalini, Surface, Matthew, Merchant, Kalpana, Alcalay, Roy N, Mann, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933820/ https://www.ncbi.nlm.nih.gov/pubmed/33481347 http://dx.doi.org/10.15252/emmm.202013257 |
Ejemplares similares
-
Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease
por: Karayel, Ozge, et al.
Publicado: (2022) -
Plasma Glucosylsphingosine in
GBA1
Mutation Carriers with and without Parkinson's Disease
por: Surface, Matthew, et al.
Publicado: (2021) -
Accurate MS-based Rab10 Phosphorylation Stoichiometry Determination as Readout for LRRK2 Activity in Parkinson's Disease
por: Karayel, Özge, et al.
Publicado: (2020) -
Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s disease
por: Hadisurya, Marco, et al.
Publicado: (2023) -
The structural context of posttranslational modifications at a proteome-wide scale
por: Bludau, Isabell, et al.
Publicado: (2022)